wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47429093-2E1D3E07-933E-4000-B8BE-D357C94C04A5
Q47429093-2E1D3E07-933E-4000-B8BE-D357C94C04A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47429093-2E1D3E07-933E-4000-B8BE-D357C94C04A5
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.
P2860
Q47429093-2E1D3E07-933E-4000-B8BE-D357C94C04A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47429093-2E1D3E07-933E-4000-B8BE-D357C94C04A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86483ef2662cb171babeafcea48ce3883a7081be
P2860
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.